5-methyl-2-(piperazin-1-yl)benzo[d]oxazole | 199292-73-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: 5-methyl-2-(piperazin-1-yl)benzo[d]oxazole
• 英文别名: 5-methyl-2-(1-piperazinyl)benzoxazole；5-Methyl-2-(piperazin-1-yl)-1,3-benzoxazole；5-methyl-2-piperazin-1-yl-1,3-benzoxazole
• CAS: 199292-73-4
• 化学式: C₁₂H₁₅N₃O
• mdl: MFCD11053076
• 分子量: 217.271
• InChiKey: LMWRWGVXGSCKRR-UHFFFAOYSA-N

物化性质

• 熔点：
  90-92 °C
• 沸点：
  361.9±52.0 °C(Predicted)
• 密度：
  1.179±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  16
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.416
• 拓扑面积：
  41.3
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  邻氨基对甲苯酚 在 potassium hydroxide 作用下， 以 乙醇 、 甲苯 为溶剂， 反应 26.0h， 生成 5-methyl-2-(piperazin-1-yl)benzo[d]oxazole
  参考文献：
  名称：

  Venkatachalam; Pierens; Reutens, Letters in Organic Chemistry, 2010, vol. 7, # 7, p. 519 - 527

  摘要：

  DOI：

文献信息

• ANTHELMINTIC COMPOUNDS AND COMPOSITIONS AND METHOD OF USING THEREOF
  申请人：Meng Charles Q.

  公开号：US20140142114A1

  公开（公告）日：2014-05-22

  The present invention relates to novel anthelmintic compounds of formula (I) below: wherein Y and Z are independently a bicyclic carbocyclic or a bicyclic heterocyclic group, or one of Y or Z is a bicyclic carbocyclic or a bicyclic heterocyclic group and the other of Y or Z is alkyl, alkenyl, alkynyl, cycloalkyl, phenyl, heterocyclyl or heteroaryl, and variables X 1 , X 2 , X 3 , X 4 , X 5 , X 6 , X 7 and X 8 are as defined herein. The invention also provides for veterinary compositions comprising the anthelmintic compounds of the invention, and their uses for the treatment and prevention of parasitic infections in animals.

  本发明涉及以下式（I）的新型驱虫化合物： 其中 Y和Z分别是双环碳环或双环杂环基团，或者Y或Z中的一个是双环碳环或双环杂环基团，另一个是烷基，烯基，炔基，环烷基，苯基，杂环基或杂芳基，以及变量X 1 ，X 2 ，X 3 ，X 4 ，X 5 ，X 6 ，X 7 和X 8 如本文所定义。本发明还提供了包含本发明的驱虫化合物的兽药组合物，以及它们用于治疗和预防动物寄生虫感染的用途。
• [EN] HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES EN TANT QU'INHIBITEURS DE KINASE
  申请人：NUVATION BIO INC

  公开号：WO2021003314A1

  公开（公告）日：2021-01-07

  Heterocyclic compounds as CDK4 or CDK6 or other CDK inhibitors are provided. The compounds may find use as therapeutic agents for the treatment of diseases and may find particular use in oncology.

  提供异环化合物作为CDK4或CDK6或其他CDK抑制剂。这些化合物可能作为治疗疾病的治疗剂，特别是在肿瘤学方面可能具有特殊用途。
• [EN] HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES UTILISÉS EN TANT QU'INHIBITEURS DE KINASES
  申请人：NUVATION BIO INC

  公开号：WO2021030620A1

  公开（公告）日：2021-02-18

  Heterocyclic compounds as CDK4 or CDK6 or other CDK inhibitors are provided. The compounds may find use as therapeutic agents for the treatment of diseases and may find particular use in oncology.

  提供了作为CDK4或CDK6或其他CDK抑制剂的杂环化合物。这些化合物可以作为治疗剂用于治疗疾病，特别是在肿瘤学领域中有特殊的应用。
• Serotonin 5-HT, receptor partial activator
  申请人：——

  公开号：US20010016579A1

  公开（公告）日：2001-08-23

  This invention provides a serotonin 5-HT 3 receptor partial activator which has a serotonin 5-HT 3 receptor activating action, in addition to its serotonin 5-HT 3 receptor antagonism, and does not cause constipation as a side effect. Particularly, based on the finding that newly synthesized benzoxazole derivatives typified by the compounds of the following formula (2) have strong serotonin 5-HT 3 receptor antagonism and serotonin 5-HT 3 receptor activating action, this invention provides these benzoxazole derivatives as serotonin 5-HT 3 receptor partial activators. 1 In the above formula, R 1 to R 4 may be the same or different from one another and each represents a hydrogen atom, a halogen atom, a substituted or unsubstituted lower alkyl group, a substituted or unsubstituted lower alkenyl group or a substituted or unsubstituted amino group, or two groups of R 1 and R 2 may be linked together to form a ring structure, namely benzene ring; R 5 represents a hydrogen atom, a substituted or unsubstituted lower alkyl group or a substituted or unsubstituted lower alkenyl group; and m is an integer of 1 to 4.

  本发明提供了一种5-HT3受体部分激动剂，该激动剂具有5-HT3受体激活作用，除了其5-HT3受体拮抗作用外，不会引起便秘等副作用。特别是，基于新合成的苯并咪唑衍生物发现，该衍生物以以下式子（2）的化合物为代表具有强烈的5-HT3受体拮抗作用和5-HT3受体激活作用，本发明提供这些苯并咪唑衍生物作为5-HT3受体部分激动剂。在上述公式中，R1到R4可以相同也可以不同，每个表示氢原子、卤素原子、取代或未取代的低级烷基、取代或未取代的低级烯基或取代或未取代的氨基；或R1和R2的两个基团可以连接在一起形成环结构，即苯环；R5表示氢原子、取代或未取代的低级烷基或取代或未取代的低级烯基；m是1到4的整数。
• Serotonin 5-HT3 receptor partial activator
  申请人：MEIJI SEIKA KAISHA, LTD.

  公开号：US20030013730A1

  公开（公告）日：2003-01-16

  This invention provides a serotonin 5-HT 3 receptor partial activator which has a serotonin 5-HT 3 receptor activating action, in addition to its serotonin 5-HT 3 receptor antagonism, and does not cause constipation as a side effect. Particularly, based on the finding that newly synthesized benzoxazole derivatives typified by the compounds of the following formula (2) have strong serotonin 5-HT 3 receptor antagonism and serotonin 5-HT 3 receptor activating action, this invention provides these benzoxazole derivatives as serotonin 5-HT 3 receptor partial activators. 1 In the above formula, R 1 to R 4 may be the same or different from one another and each represents a hydrogen atom, a halogen atom, a substituted or unsubstituted lower alkyl group, a substituted or unsubstituted lower alkenyl group or a substituted or unsubstituted amino group, or two groups of R 1 and R 2 may be linked together to form a ring structure, namely benzene ring; R 5 represents a hydrogen atom, a substituted or unsubstituted lower alkyl group or a substituted or unsubstituted lower alkenyl group; and m is an integer of 1 to 4.

  该发明提供了一种5-HT3受体部分激动剂，具有5-HT3受体激活作用，除了5-HT3受体拮抗作用外，不会引起便秘等副作用。特别地，基于新合成的苯并噁唑衍生物的发现，该衍生物以以下公式（2）的化合物为代表，具有强烈的5-HT3受体拮抗作用和5-HT3受体激活作用，该发明提供这些苯并噁唑衍生物作为5-HT3受体部分激动剂。在上述公式中，R1至R4可以相同或不同，每个代表氢原子、卤素原子、取代或未取代的低级烷基、取代或未取代的低级烯基或取代或未取代的氨基，或R1和R2的两个基团可以连接在一起形成环结构，即苯环；R5代表氢原子、取代或未取代的低级烷基或取代或未取代的低级烯基；m是1到4的整数。